Alpha antagonists from initial concept to routine clinical practice

Size: px
Start display at page:

Download "Alpha antagonists from initial concept to routine clinical practice"

Transcription

1 european urology 50 (2006) available at journal homepage: Editorial 50th Anniversary Alpha antagonists from initial concept to routine clinical practice Christopher Chapple * Department of Urology, Royal Hallamshire Hospital, Sheffield, United Kingdom It is a great honour and a pleasure for me to participate in this celebration of the 50th volume of European Urology by commenting on this landmark review paper by Marco Caine, who was the pioneer of pharmacotherapy for lower urinary tract symptoms (LUTS) suggestive of benign prostatic outlet obstruction (BOO; previously referred to as symptomatic benign prostatic hyperplasia [BPH]), which are so common in ageing men. This paper contains a number of comments that remain equally correct 29 yr later in 2006!. At the present stage our understanding of this field is relatively simplistic and does not take into account the close interdependence and integration that exists between the sympathetic and parasympathetic and perhaps also somatic nervous systems. There is steadily increasing evidence of both peripheral and central interactions between these systems [1]. When Professor Caine wrote this review paper, the emphasis was on voiding dysfunction, as shown by the title disorders of micturition and, indeed, still has been until recently. We now realise that the most bothersome symptoms are those affecting storage and the emphasis of treatment is shifting to encompass both storage and voiding symptoms [2]. At the time Professor Caine wrote this innovative paper and certainly until 15 yr ago, surgery and watchful waiting were the only widely accepted management options for BPH/LUTS and benign prostatic obstruction (BPO). There has been an enormous decline in the popularity of surgery and it is now clearly apparent that medication is the most frequently used treatment modality for BPH/ LUTS. Arguably, this has therefore been the most major change in urologic clinical practice in the last decade. Operative intervention is increasingly considered rather radical from the patient s perspective and not surprisingly many patients feel reluctant to undergo surgery and prefer a less invasive intervention such as medical therapy, before contemplating surgery. Although absolute indications for surgery still exist, in the last decade the number of patients undergoing operations for BPH has decreased by about 60% across Europe. This trend has been encouraged not only by increased patient awareness of the availability of effective contemporary pharmacotherapy, but has also been encouraged by an increased understanding of the complications of surgery, in particular that it can be associated with significant morbidity, such as irreversible incontinence and loss of sexual function with subsequent impairment of a patient s quality of life. Professor Caine and his coworkers were the first to emphasise the importance of the a-adrenergic innervation of the bladder outflow tract and to carry out initial characterisation of these in man. The success of this work is evident if one considers that it is standard knowledge in urology that prostatic smooth muscle tone is dependent on the release of noradrenaline (NA) from adrenergic nerves, thereby stimulating a 1 -adrenoceptors (ARs) on smooth muscle of the prostatic stroma, bladder neck, and urethra. * Tel ; Fax: address: c.r.chapple@sheffield.ac.uk /$ see back matter # 2006 European Association of Urology. Published by Elsevier B.V. All rights reserved. doi: /j.eururo

2 636 european urology 50 (2006) Although storage symptoms are clearly associated with bladder dysfunction, often assumed to be secondary to outflow obstruction, there is no convincing evidence for a direct correlation between the size of the prostate, BOO, and LUTS [2]. Prostatic and urethral a-ars are considered to mediate the dynamic component of obstruction and a 1 -AR antagonists improve both LUTS and flow rate in patients with BPH [3]. Conversely, a direct relationship between the amount of prostatic smooth muscle and dynamic obstruction (as assessed by the response to a 1 -AR blockade) has been demonstrated [4]; therefore, it is logical to assume that these receptors mediate some of the symptoms. On the other hand, many patients who have undergone prostatectomy, which should relieve obstruction, still experience persistent storage symptoms [5]; clearly, mechanisms outside the prostate involving a 1 -ARs may be involved in the pathogenesis of storage symptoms. LUTS can be caused by a number of factors and along with the prostate, there are several possible sites of action of a-ar antagonists: Prostatic stroma-smooth musculature Detrusor, trigone, urethral smooth muscle Detrusor, trigone, urethral urothelium Ganglia Spinal or supraspinal structures within the central nervous system It has become clear that the effects of a-blockers on relieving BOO are moderate at best [6], and this effect alone is insufficient to explain the improvement seen in storage symptoms. Therefore, newer concepts have been advanced, with the suggestion that a 1 -adrenoceptors in the bladder or spinal cord are possible mediators of a-blocker-induced symptom relief [7,8]. Clearly this remains hypothetical and the specific mechanisms by which such effects could occur need to be defined. Although it is now clear that a-ar antagonist effects on BOO are mediated predominantly if not exclusively by a 1A - ARs in the bladder neck and prostate, it remains speculative that clinical effects on the bladder and spinal cord, if they occur, are via an action on a 1D - ARs. This needs to be verified by future research. Despite the observations noted above, it must be concluded that just as suggested by Caine 29 yr ago, the principal motor control of the prostate is still, in 2006, considered to be via an action on a 1 -ARs localised predominantly within the stromal compartment of the prostate. Although Caine introduced the nonselective a 1/2 -antagonist phenoxybenzamine, its use was discontinued because of toxicity and sideeffect issues; nevertheless, he was involved in the initial work using the first a 1 -antagonist prazosin. The legacy of Caine s work is that a 1 -AR antagonists are now well established as the most common treatment for BPH/LUTS. Indeed, systematic analysis of placebo-controlled studies shows that commonly used a 1 -AR antagonists (doxazosin, terazosin, alfuzosin, tamsulosin) are similarly effective and statistically significantly superior to placebo in improving urinary flow and reducing symptoms [3]. References [1] Caine M. The importance of adrenergic receptors in disorders of micturition. Eur Urol 1977;3:1 6. [2] Chapple CR, Roehrborn CG. A shifted paradigm for the further understanding, evaluation and treatment of lower urinary tract symptoms in men: focus on the bladder. Eur Urol 2006;49: [3] Chapple C, Artibani W, Berges R, et al. New medical developments in the management of LUTS in adult men. In: McConnell J, Abrams P, Denis L, Khoury S, Roehrborn, C, editors. Male Lower Urinary Tract Dysfunction. Jersey, UK: Health Publication Ltd; p ISBN: [4] Shapiro E, Hartano V, Lepor H. The response to alpha blockade in benign prostatic hyperplasia is related to the percent area density of prostate smooth muscle. Prostate 1992;21: [5] Hald T, et al. In: Abrams P, Khoury S, Wein A, editors. Pathophysiology of the urinary bladder in obstruction and aging. In: Incontinence. First International Consultation on Incontinence. United Kingdom: Health Publication, Plymbridge Distributors; p [6] Kortmann BBM, Floratos DL, Kiemeney LALM, Wijkstra H, de la Rosette JJMCH. Urodynamic effects of alphaadrenoceptor blockers: a review of clinical trials. Urology 2003;62:1 9. [7] Michel MC. Potential role of a 1 -adrenoceptor subtypes in the aetiology of LUTS. Eur Urol Suppl 2002;1(9):5 13. [8] Roehrborn CG, Schwinn DA. a 1 -Adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia. J Urol 2004;171:

3 european urology 50 (2006)

4 638 european urology 50 (2006)

5 european urology 50 (2006)

6 640 european urology 50 (2006)

7 european urology 50 (2006)

8 642 european urology 50 (2006)

Efficacy of Silodosin for Relieving Benign Prostatic Obstruction: Prospective Pressure Flow Study

Efficacy of Silodosin for Relieving Benign Prostatic Obstruction: Prospective Pressure Flow Study Efficacy of Silodosin for Relieving Benign Prostatic Obstruction: Prospective Pressure Flow Study Yoshihisa Matsukawa,* Momokazu Gotoh, Tomonori Komatsu, Yasuhito Funahashi, Naoto Sassa and Ryohei Hattori

More information

Key words: Lower Urinary Tract Symptoms (LUTS), Prostatic Hyperplasia, Alpha-1 Adrenoceptor Antagonists, Tamsulosin, Terazosin.

Key words: Lower Urinary Tract Symptoms (LUTS), Prostatic Hyperplasia, Alpha-1 Adrenoceptor Antagonists, Tamsulosin, Terazosin. The Professional Medical Journal DOI: 10.17957/TPMJ/17.4102 ORIGINAL PROF-4102 PROSTATIC HYPERPLASIA; COMPARISON BETWEEN TAMSULOSIN AND TERAZOSIN FOR EFFICACY IN MEDICAL MANAGEMENT OF LOWER URINARY TRACT

More information

Office Management of Benign Prostatic Enlargement

Office Management of Benign Prostatic Enlargement Focus on CME at McGill University Office Management of Benign Prostatic Enlargement Symptomatic benign prostate enlargement is a common medical problem encountered in our aging society. Watchful waiting,

More information

Therapeutic Strategies for Managing BPH Progression

Therapeutic Strategies for Managing BPH Progression european urology supplements 5 (2006) 997 1003 available at www.sciencedirect.com journal homepage: www.europeanurology.com Therapeutic Strategies for Managing BPH Progression John M. Fitzpatrick a, *,

More information

New Treatment Modalities for Benign Prostatic Hyperplasia. Seung-June Oh, MD Department of Urology, Seoul National University Hospital

New Treatment Modalities for Benign Prostatic Hyperplasia. Seung-June Oh, MD Department of Urology, Seoul National University Hospital New Treatment Modalities for Benign Prostatic Hyperplasia Seung-June Oh, MD Department of Urology, Seoul National University Hospital Options for Treating BPH Pharmacotherapy blocker Agents for BPH + OAB

More information

Diagnostic approach to LUTS in men. Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center

Diagnostic approach to LUTS in men. Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center Diagnostic approach to LUTS in men Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center Classification of LUTS Storage symptoms Voiding symptoms Post micturition

More information

Benign Prostatic Hyperplasia (BPH):

Benign Prostatic Hyperplasia (BPH): Benign Prostatic Hyperplasia (BPH): Evidence Based Guidelines for Primary Care Providers Jeanne Martin, DNP, ANP-BC Objectives 1. Understand the pathophysiology and prevalence of BPH 2. Select the appropriate

More information

The Evolution of Combination Therapy. US men eligible for BPH treatment * with projected population changes

The Evolution of Combination Therapy. US men eligible for BPH treatment * with projected population changes The Management of BPH & The Impact of Combination Therapy Results Combination of Avodart and Tamsulosin (CombAT) Medical Therapy of Prostate Symptoms (MTOPS) Dr. Jack Barkin, md, fics, facs, dabu, Mcert

More information

How Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia?

How Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia? available at www.sciencedirect.com journal homepage: www.europeanurology.com How Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia?

More information

Combination Drug Therapy for Benign Prostatic Hyperplasia (BPH)

Combination Drug Therapy for Benign Prostatic Hyperplasia (BPH) The Annals of African Surgery www.sskenya.org Combination Drug Therapy for Benign Prostatic Hyperplasia (BPH) Author: Oliech J.S. FRCS, Affiliation: Department of Surgery, University of Nairobi. P.O. Box

More information

Abstract. Key words Trial without catheter, Acute urinary retention, Benign prostatic hyperplasia, Introduction

Abstract. Key words Trial without catheter, Acute urinary retention, Benign prostatic hyperplasia, Introduction The role of sustained-released alfuzosin in the treatment of acute urinary retention Mohamed Fawzi Ahmed. Department of Surgery, Ninevah College of Medicine, University of Mosul. Abstract To see whether

More information

MMM. Topic The use of Tadalafil 5mg daily for the treatment of BPH-LUTS

MMM. Topic The use of Tadalafil 5mg daily for the treatment of BPH-LUTS Dr Tan & Partners MMM Vol. 1 No. 1 Morbidity & Mortality Meeting 14 th November 2014 Introduction Topic The use of Tadalafil 5mg daily for the treatment of BPH-LUTS Tadalafil 5mg daily is a well established

More information

During the past decade, numerous

During the past decade, numerous Benign prostatic hyperplasia (BPH) is one of the most common diseases of aging men. It is estimated that by age 60 years, greater than 50% of men will have histologically documented evidence of the disease.

More information

Efficacy and safety of tamsulosin OCAS

Efficacy and safety of tamsulosin OCAS Original Article EFFICACY AND SAFETY OF TAMSULOSIN OCAS SPEAKMAN Efficacy and safety of tamsulosin OCAS MARK SPEAKMAN Taunton and Somerset Hospital, Taunton, UK The efficacy and safety of a new tablet

More information

Benign Prostatic Hyperplasia. Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary

Benign Prostatic Hyperplasia. Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary Benign Prostatic Hyperplasia Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied,

More information

Original Article Japanese Urological Association. International Journal of Urology (2006) 13,

Original Article Japanese Urological Association. International Journal of Urology (2006) 13, Blackwell Publishing AsiaMelbourne, AustraliaIJUInternational Journal of Urology0919-81722006 Blackwell Publishing Asia Pty Ltd2006130014051409Original ArticleTamsulosin vs doxazosin in BPH D Rahardjo

More information

Original Article. J Fac Med Baghdad 119. Nibbras I. AL-Hamdani* Ali W. Zeki*** Introduction:

Original Article. J Fac Med Baghdad 119. Nibbras I. AL-Hamdani* Ali W. Zeki*** Introduction: Original Article The Efficacy of Solifenacin Added to Α-Adrenergic Antagonists in the Treatment of Lower Urinary Tract Symptoms in Males with Benign Prostate Hyperplasia (The Iraqi Experience) Nibbras

More information

Index. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Ablative therapies, transurethral needle ablation, Adverse events, sexual side effects of BPH Aging, and incidence of BPH associated with

More information

MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH

MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH INTRODUCTION (1) Part of male sexual reproductive organ Size

More information

Diagnosis and Mangement of Nocturia in Adults

Diagnosis and Mangement of Nocturia in Adults Diagnosis and Mangement of Nocturia in Adults Christopher Chapple Professor of Urology Sheffield Teaching Hospitals University of Sheffield Sheffield Hallam University UK 23 rd October 2015 Terminology

More information

The Egyptian Journal of Hospital Medicine (January 2019) Vol. 74 (6), Page

The Egyptian Journal of Hospital Medicine (January 2019) Vol. 74 (6), Page The Egyptian Journal of Hospital Medicine (January 2019) Vol. 74 (6), Page 1377-1386 Evaluation of Silodosin in Comparison to Tamuslosin in Treatment of Benign Prostatic Hyperplasia with lower Urinary

More information

Ejaculation. Emission. Ejection. Orgasm

Ejaculation. Emission. Ejection. Orgasm Ejaculation Emission Ejection Orgasm Ejaculation sc T10-L2 S2-4 Emission: vas deferens, prostate, bladder neck Post. Urethra distention Ejection: Pelvic Floor / bulbocavernous muscle contraction Orgasm:

More information

Overview. Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia. Iain McAuley September 15, 2014

Overview. Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia. Iain McAuley September 15, 2014 Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia Iain McAuley September 15, 2014 Overview Review of the most recent guidelines for ED and BPH ED Guidelines CUA 2006 AUA 2011

More information

The Journal of International Medical Research 2012; 40:

The Journal of International Medical Research 2012; 40: The Journal of International Medical Research 2012; 40: 899 908 Comparison of α-blocker Monotherapy and α-blocker Plus 5α-Reductase Inhibitor Combination Therapy Based on Prostate Volume for Treatment

More information

PATIENT INFORMATION 2017 NeoTract, Inc. All rights reserved. Printed in the USA. MAC Rev A

PATIENT INFORMATION 2017 NeoTract, Inc. All rights reserved. Printed in the USA. MAC Rev A PATIENT INFORMATION OVER 70% OF MEN IN THEIR 60s HAVE SYMPTOMS OF BPH 1 BPH affects more than 500 million men worldwide, with many men suffering from symptoms of enlarged prostate. 1 You no longer have

More information

Double-Blind Placebo-Controlled Study of PR-2000 in the Management of Benign Prostatic Hyperplasia

Double-Blind Placebo-Controlled Study of PR-2000 in the Management of Benign Prostatic Hyperplasia [The Antiseptic (2002): (99), 1, 8-11] Double-Blind Placebo-Controlled Study of PR-2000 in the Management of Benign Prostatic Hyperplasia Garg, S.K., M.S., D.N.B. (Surgery), M.Ch., D.N.B. (Urology) Bombay

More information

Chapter 4: Research and Future Directions

Chapter 4: Research and Future Directions Chapter 4: Research and Future Directions Introduction Many of the future research needs listed in the 1994 Agency for Health Care Policy and Research (AHCPR) clinical practice guideline Benign Prostatic

More information

CHAPTER 6. M.D. Eckhardt, G.E.P.M. van Venrooij, T.A. Boon. hoofdstuk :49 Pagina 89

CHAPTER 6. M.D. Eckhardt, G.E.P.M. van Venrooij, T.A. Boon. hoofdstuk :49 Pagina 89 hoofdstuk 06 19-12-2001 09:49 Pagina 89 Urethral Resistance Factor (URA) Versus Schäfer s Obstruction Grade and Abrams-Griffiths (AG) Number in the Diagnosis of Obstructive Benign Prostatic Hyperplasia

More information

EAU GUIDELINES POCKET EDITION 3

EAU GUIDELINES POCKET EDITION 3 EAU GUIDELINES POCKET EDITION 3 CONTENTS: BENIGN PROSTATIC HYPERPLASIA URINARY INCONTINENCE UROLITHIASIS 2 3 EAU POCKET GUIDELINES POCKET EDITION 3 This is one of a series of convenient pocket size books

More information

ÉZER A. MELO, DEMERVAL MATTOS JR., LUIS A. S. RIOS. Division of Urology, Hospital do Servidor Público Estadual de São Paulo, São Paulo, SP, Brazil

ÉZER A. MELO, DEMERVAL MATTOS JR., LUIS A. S. RIOS. Division of Urology, Hospital do Servidor Público Estadual de São Paulo, São Paulo, SP, Brazil Clinical Urology Brazilian Journal of Urology Official Journal of the Brazilian Society of Urology Vol. 28 (1): 25-32, January - February, 2002 A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY, TO

More information

Treatment Patterns in Alpha-Blocker Therapy for Benign Prostatic Hyperplasia

Treatment Patterns in Alpha-Blocker Therapy for Benign Prostatic Hyperplasia 510732JMHXXX10.1177/1557988313510732American Journal of Men s HealthSchoenfeld et al. research-article2013 Article Treatment Patterns in Alpha-Blocker Therapy for Benign Prostatic Hyperplasia American

More information

GUIDELINES ON NON-NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION (BPO)

GUIDELINES ON NON-NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION (BPO) GUIDELINES ON NON-NEUROGENIC MLE LUTS INCLUDING BENIGN PROSTTIC OBSTRUCTION (BPO) (Text update pril 2014) S. Gravas (chair),. Bachmann,. Descazeaud, M. Drake, C. Gratzke, S. Madersbacher, C. Mamoulakis,

More information

DOWNLOAD OR READ : TREATMENT OF BENIGN PROSTATIC HYPERPLASIA PDF EBOOK EPUB MOBI

DOWNLOAD OR READ : TREATMENT OF BENIGN PROSTATIC HYPERPLASIA PDF EBOOK EPUB MOBI DOWNLOAD OR READ : TREATMENT OF BENIGN PROSTATIC HYPERPLASIA PDF EBOOK EPUB MOBI Page 1 Page 2 treatment of benign prostatic hyperplasia treatment of benign prostatic pdf treatment of benign prostatic

More information

This Special Report supplement

This Special Report supplement ...INTRODUCTION... Overactive Bladder: Defining the Disease Alan J. Wein, MD This Special Report supplement to The American Journal of Managed Care features proceedings from the workshop, Overactive Bladder:

More information

Medical Therapy for Benign Prostatic Hyperplasia Present and Future Impact

Medical Therapy for Benign Prostatic Hyperplasia Present and Future Impact REPORTS Medical Therapy for Benign Prostatic Hyperplasia Present and Future Impact Muta M. Issa, MD, MBA; Timothy S. Regan, BPharm, RPh, CPh Abstract The purpose of this manuscript is to provide clinicians,

More information

Hyoung Woo Kim, Dae Geun Moon, Hyun Min Kim, Jong Ho Hwang, Soon Chan Kim, Sam Geuk Nam, Jun Tag Park

Hyoung Woo Kim, Dae Geun Moon, Hyun Min Kim, Jong Ho Hwang, Soon Chan Kim, Sam Geuk Nam, Jun Tag Park www.kjurology.org http://dx.doi.org/10.4111/kju.2011.52.10.681 Voiding Dysfunction Effect of Shifting from Combination Therapy to Monotherapy of α-blockers or 5α-Reductase Inhibitors on Prostate Volume

More information

TREATMENT METHODS FOR DISORDERS OF SMALL ANIMAL BLADDER FUNCTION

TREATMENT METHODS FOR DISORDERS OF SMALL ANIMAL BLADDER FUNCTION Vet Times The website for the veterinary profession https://www.vettimes.co.uk TREATMENT METHODS FOR DISORDERS OF SMALL ANIMAL BLADDER FUNCTION Author : SIMONA T RADAELLI Categories : Vets Date : July

More information

Profile of Silodosin. Francesco Montorsi * Article info. Abstract

Profile of Silodosin. Francesco Montorsi * Article info. Abstract EUROPEAN UROLOGY SUPPLEMENTS 9 (2010) 491 495 available at www.sciencedirect.com journal homepage: www.europeanurology.com Profile of Silodosin Francesco Montorsi * Department of Urology, University Vita-Salute

More information

Guideline for the primary care management of male lower urinary tract symptoms

Guideline for the primary care management of male lower urinary tract symptoms review Article GUIDELINES FOR LUTS M.J. SPEAKMAN et al. As my Comment in the first section of the journal suggested, the MTOPS results have offered the possibility to general practitioners of reducing

More information

α 1 adrenergic receptor antagonists versus placebo for female lower urinary tract symptoms: A meta analysis

α 1 adrenergic receptor antagonists versus placebo for female lower urinary tract symptoms: A meta analysis EXPERIMENTAL AND THERAPEUTIC MEDICINE 10: 251-256, 2015 α 1 adrenergic receptor antagonists versus placebo for female lower urinary tract symptoms: A meta analysis PENG ZHANG 1, WAN LI HU 1, BEI CHENG

More information

Index. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Ablation, of prostate, holmium laser, 485 495 African prune tree (Pygeum africanum), 454 455 Alfuzosin, 445 446 Alpha-adrenergic agonists,

More information

GUIDELINES ON NON-NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION

GUIDELINES ON NON-NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION GUIDELINES ON NON-NEUROGENIC MLE LUTS INCLUDING BENIGN PROSTTIC OBSTRUCTION (Text update March 2015) S. Gravas (Chair), T. Bach,. Bachmann, M. Drake, M. Gacci, C. Gratzke, S. Madersbacher, C. Mamoulakis,

More information

Management of LUTS after TURP and MIT

Management of LUTS after TURP and MIT Management of LUTS after TURP and MIT Hong Sup Kim Konkuk University TURP & MIT TURP : Gold standard MIT TUIP TUNA TUMT HIFU LASER Nd:YAG, ILC, HoLRP, KTP LUTS after TURP and MIT Improved : about 70% Persistent

More information

Voiding Dysfunction Block lecture, 5 th year student. Choosak Pripatnanont, Department of Surgery, PSU.

Voiding Dysfunction Block lecture, 5 th year student. Choosak Pripatnanont, Department of Surgery, PSU. Voiding Dysfunction 2009 Block lecture, 5 th year student. Choosak Pripatnanont, Department of Surgery, PSU. Objectives Understand and explain physiologic function and dysfunction of lower urinary tract.

More information

Association of BPH with OAB: The Plumbing or the Pump?

Association of BPH with OAB: The Plumbing or the Pump? Association of BPH with OAB: The Plumbing or the Pump? Ryan P. Terlecki, MD FACS Associate Professor of Urology Director, Men s Health Clinic Director, GURS Fellowship in Reconstructive Urology, Prosthetic

More information

LONG-TERM SAFETY AND EFFICACY OF TAMSULOSIN FOR THE TREATMENT OF LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA

LONG-TERM SAFETY AND EFFICACY OF TAMSULOSIN FOR THE TREATMENT OF LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA 0022-5347/03/1702-0498/0 Vol. 170, 498 502, August 2003 THE JOURNAL OF UROLOGY Printed in U.S.A. Copyright 2003 by AMERICAN UROLOGICAL ASSOCIATION DOI: 10.1097/01.ju.0000076140.68657.fd LONG-TERM SAFETY

More information

The Effect of Tamsulosin on the RestingTone and the ContractileBehaviouroftheFemaleUrethra:AFunctional Urodynamic Study in Healthy Women

The Effect of Tamsulosin on the RestingTone and the ContractileBehaviouroftheFemaleUrethra:AFunctional Urodynamic Study in Healthy Women European Urology European Urology 46 (24) 235 24 The Effect of Tamsulosin on the RestingTone and the ContractileBehaviouroftheFemaleUrethra:AFunctional Urodynamic Study in Healthy Women André Reitz a,*,

More information

50% of men. 90% of men PATIENT FACTSHEET: BPH CONDITION AND TREATMENTS. Want more information? What are the symptoms?

50% of men. 90% of men PATIENT FACTSHEET: BPH CONDITION AND TREATMENTS. Want more information? What are the symptoms? PATIENT FACTSHEET: BPH CONDITION AND TREATMENTS What is Benign Prostatic Hyperplasia (enlarged prostate)? Benign prostatic hyperplasia (BPH) is a noncancerous enlargement of the prostate, the gland that

More information

Forum Minireview. Martin C. Michel1, *

Forum Minireview. Martin C. Michel1, * J Pharmacol Sci 112, 151 157 (21) Journal of Pharmacological Sciences 21 The Japanese Pharmacological Society Forum Minireview The Forefront for Novel Therapeutic Agents Based on the Pathophysiology of

More information

THE EVOLUTION OF DETRUSOR OVERACTIVITY AFTER WATCHFUL WAITING, MEDICAL THERAPY AND SURGERY IN PATIENTS WITH BLADDER OUTLET OBSTRUCTION

THE EVOLUTION OF DETRUSOR OVERACTIVITY AFTER WATCHFUL WAITING, MEDICAL THERAPY AND SURGERY IN PATIENTS WITH BLADDER OUTLET OBSTRUCTION 0022-5347/03/1692-0535/0 Vol. 169, 535 539, February 2003 THE JOURNAL OF UROLOGY Printed in U.S.A. Copyright 2003 by AMERICAN UROLOGICAL ASSOCIATION DOI: 10.1097/01.ju.0000045600.69261.73 THE EVOLUTION

More information

Benign Prostatic Hyperplasia (BPH) Important Papers / Landmark. Vijayan Manogran

Benign Prostatic Hyperplasia (BPH) Important Papers / Landmark. Vijayan Manogran Benign Prostatic Hyperplasia (BPH) Important Papers / Landmark Studies Vijayan Manogran MTOPS & CombAT PLESS SMART ALTESS ALF-ONE VA PREDICT EPICS Landmark Studies MTOPS Medical Therapy of Prostatic Symptoms

More information

Signal transduction underlying the control of urinary bladder smooth muscle tone Puspitoayu, E.

Signal transduction underlying the control of urinary bladder smooth muscle tone Puspitoayu, E. UvA-DARE (Digital Academic Repository) Signal transduction underlying the control of urinary bladder smooth muscle tone Puspitoayu, E. Link to publication Citation for published version (APA): Puspitoayu,

More information

BPH: a present and future perspective on health impact

BPH: a present and future perspective on health impact BPH: a present and future perspective on health impact Burden of disease in men with moderate LUTS Dalibor Pacík This presentation is financially supported by GlaxoSmithKline. CZ/DUTT/0019/12 Men with

More information

Benign Prostatic Hyperplasia: Update on Innovative Current Treatments

Benign Prostatic Hyperplasia: Update on Innovative Current Treatments Benign Prostatic Hyperplasia: Update on Innovative Current Treatments Michael Ferrandino, MD As.soc Professor Director of Minimally Invasive Urologic Surgery Division of Urologic Surgery Duke University

More information

PRABHAKAR SINGH*, MANOJ INDURKAR, AMITA SINGH, PALLAVI INDURKAR

PRABHAKAR SINGH*, MANOJ INDURKAR, AMITA SINGH, PALLAVI INDURKAR Academic Sciences International Journal of Current Pharmaceutical Research ISSN- 0975-7066 Vol 5, Issue 1, 2013 Research Article COMPARISON OF THE EFFICACY AND SAFETY OF TAMSULOSIN (0.4 V/S (and) FINASTERIDE

More information

Male LUTS, OAB, Sex: natural history. JR Sathiya

Male LUTS, OAB, Sex: natural history. JR Sathiya Male LUTS, OAB, Sex: natural history JR Sathiya Definitions Newer concepts of LUTs Natural history of BPH Prevalence of LUTs Definition BPH- represents a histologic diagnosis that refers to the proliferation

More information

Chapter 3: Results of the Treatment Outcomes Analyses

Chapter 3: Results of the Treatment Outcomes Analyses Chapter 3: Results of the Treatment Outcomes Analyses TABLE OF CONTENTS INTRODUCTION... 3 WATCHFUL WAITING... 11 STUDY OUTCOMES... 11 MEDICAL THERAPIES... 13 ALPHA-ADRENERGIC ANTAGONISTS (ALPHA-BLOCKERS)...

More information

The Evidence for Antimuscarinic Agents in Female Mixed Urinary Incontinence

The Evidence for Antimuscarinic Agents in Female Mixed Urinary Incontinence european urology supplements 5 (2006) 849 853 available at www.sciencedirect.com journal homepage: www.europeanurology.com The Evidence for Antimuscarinic Agents in Female Mixed Urinary Incontinence Stefano

More information

Adrenoceptor Antagonist Tamsulosin for the Treatment of Voiding Symptoms Improves Nocturia and Sleep Quality in Women. The α 1 FEMALE UROLOGY

Adrenoceptor Antagonist Tamsulosin for the Treatment of Voiding Symptoms Improves Nocturia and Sleep Quality in Women. The α 1 FEMALE UROLOGY The α 1 Adrenoceptor Antagonist Tamsulosin for the Treatment of Voiding Symptoms Improves Nocturia and Sleep Quality in Women Sun-Ouck Kim, Hyang Sik Choi, Dongdeuk Kwon FEMALE UROLOGY Department of Urology,

More information

Will Medical Management of Benign Prostatic Hyperplasia Result in Better or Worse Sexual Function in Men?

Will Medical Management of Benign Prostatic Hyperplasia Result in Better or Worse Sexual Function in Men? Urol Sci 2011;22(1):14 18 MINI REVIEW Will Medical Management of Benign Prostatic Hyperplasia Result in Better or Worse Sexual Function in Men? Thomas I.S. Hwang 1,2,3 * 1 Shin Kong WHS Hospital, Taipei,

More information

IJBCP International Journal of Basic & Clinical Pharmacology

IJBCP International Journal of Basic & Clinical Pharmacology Print ISSN: 2319-2003 Online ISSN: 2279-0780 IJBCP International Journal of Basic & Clinical Pharmacology DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20160772 Research Article Efficacy and safety of

More information

L ower urinary tract symptoms (LUTS) are a major health problem and are prevalent in men aged.45 years1 3.

L ower urinary tract symptoms (LUTS) are a major health problem and are prevalent in men aged.45 years1 3. OPEN SUBJECT AREAS: UROGENITAL DISEASES DRUG DEVELOPMENT Received 23 October 2013 Accepted 15 January 2014 Published 4 February 2014 Correspondence and requests for materials should be addressed to P.H.

More information

DIAGNOSED WITH BENIGN PROSTATIC HYPERPLASIA

DIAGNOSED WITH BENIGN PROSTATIC HYPERPLASIA Acta Poloniae Pharmaceutica ñ Drug Research, Vol. 74 No. 4 pp. 1247ñ1253, 2017 ISSN 0001-6837 Polish Pharmaceutical Society PHARMACOLOGY CLINICAL EVALUATION OF α-1-adrenolytics IN PATIENTS DIAGNOSED WITH

More information

a 1 -adrenoceptor antagonist on uro owmetric parameters in patients with benign prostatic hyperplasia

a 1 -adrenoceptor antagonist on uro owmetric parameters in patients with benign prostatic hyperplasia Single dose methodology to assess the in uence of an a 1 -adrenoceptor antagonist on uro owmetric parameters in patients with benign prostatic hyperplasia S. P. Curtis, 1 I. Eardley, 2 M. Boyce, 3 P. Larson,

More information

Anticholinergic medication use for female overactive bladder in the ambulatory setting in the United States.

Anticholinergic medication use for female overactive bladder in the ambulatory setting in the United States. Página 1 de 6 PubMed darifenacin vs solifenacin Display Settings:, Sorted by Recently Added Results: 5 1. Int Urogynecol J. 2013 Oct 25. [Epub ahead of print] Anticholinergic medication use for female

More information

Primary Care Evaluation and Treatment of Men With Lower Urinary Tract Symptoms

Primary Care Evaluation and Treatment of Men With Lower Urinary Tract Symptoms Primary Care Evaluation and Treatment of Men With Lower Urinary Tract Symptoms Nathan Hale, DO Kellen Choi, DO Joshua Lohri, DO From the Department of Urology at the Charleston Area Medical Center in West

More information

Impact of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Treatment with Tamsulosin and Solifenacin Combination Therapy on Erectile Function

Impact of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Treatment with Tamsulosin and Solifenacin Combination Therapy on Erectile Function www.kjurology.org DOI:10.4111/kju.2011.52.1.49 Sexual Dysfunction Impact of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Treatment with Tamsulosin and Solifenacin Combination Therapy on Erectile

More information

MEDICAL THERAPY. Endocrine Approaches. Página 1 de 5.

MEDICAL THERAPY. Endocrine Approaches. Página 1 de 5. Página 1 de 5 MEDICAL THERAPY Part of "32 - BENIGN PROSTATIC HYPERPLASIA" Use of pharmacologically defined and a variety of so-called alternative medications to attempt to improve BPH voiding dysfunction

More information

for ED and LUTS/BPH Pierre Sarkis, M.D. Assistant Professor Fellow of the European Board of Urology

for ED and LUTS/BPH Pierre Sarkis, M.D. Assistant Professor Fellow of the European Board of Urology Tadalafil 5 mg once daily for ED and LUTS/BPH Pierre Sarkis, M.D. Assistant Professor Fellow of the European Board of Urology Why this conference? Not promotional but educational The pharmacist regularly

More information

Victoria Sharp, MD, MBA, FAAFP. Clinical Professor of Urology and Family Medicine

Victoria Sharp, MD, MBA, FAAFP. Clinical Professor of Urology and Family Medicine Victoria Sharp, MD, MBA, FAAFP Clinical Professor of Urology and Family Medicine Victoria Sharp, MD, MBA, FAAFP Market Chief Medial Officer AmeriHealth Caritas Family of Companies Office phone: (515) 330-3740

More information

Prostate Disease. Chad Baxter, MD

Prostate Disease. Chad Baxter, MD Prostate Disease Chad Baxter, MD Managing BPH and LUTS Chad Baxter, MD Department of Urology cbaxter@mednet.ucla.edu 33 nd Annual UCLA Intensive Course in Geriatric Medicine & Board Review Prevalence of

More information

THE ACONTRACTILE BLADDER - FACT OR FICTION?

THE ACONTRACTILE BLADDER - FACT OR FICTION? THE ACONTRACTILE BLADDER - FACT OR FICTION? Jacob Golomb Department of Urology Chaim Sheba Medical Center Tel Hashomer NEUROGENIC UNDERACTIVE DETRUSOR Central (complete/incomplete): Spinal cord injury-

More information

LUTS after TURP: How come and how to manage? Matthias Oelke

LUTS after TURP: How come and how to manage? Matthias Oelke LUTS after TURP: How come and how to manage? Matthias Oelke Department of Urology Global Congress on LUTD, Rome, 26 th June 2015 Disclosures Consultant, speaker, trial participant and/or research grants

More information

Increasing Awareness, Diagnosis, and Treatment of BPH, LUTS, and EP

Increasing Awareness, Diagnosis, and Treatment of BPH, LUTS, and EP Introduction to Enlarged Prostate E. David Crawford, MD Professor of Surgery (Urology) and Radiation Oncology Head, Urologic Oncology E. David Crawford Endowed Chair in Urologic Oncology University of

More information

Serum Prostate-Specific Antigen as a Predictor of Prostate Volume in the Community: The Krimpen Study

Serum Prostate-Specific Antigen as a Predictor of Prostate Volume in the Community: The Krimpen Study european urology 51 (2007) 1645 1653 available at www.sciencedirect.com journal homepage: www.europeanurology.com Benign Prostatic Hyperplasia Serum Prostate-Specific Antigen as a Predictor of Prostate

More information

Evaluation and Treatment of Lower Urinary Tract Symptoms in Older Men

Evaluation and Treatment of Lower Urinary Tract Symptoms in Older Men Evaluation and Treatment of Lower Urinary Tract Symptoms in Older Men P. Abrams,*, C. Chapple, S. Khoury, C. Roehrborn and J. de la Rosette on behalf of the International Scientific Committee and members

More information

Effect of Transurethral Resection of the Prostate Based on the Degree of Obstruction Seen in Urodynamic Study

Effect of Transurethral Resection of the Prostate Based on the Degree of Obstruction Seen in Urodynamic Study www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.12.840 Voiding Dysfunction/Female Urology Effect of Transurethral Resection of the Prostate Based on the Degree of Obstruction Seen in Urodynamic

More information

= 0.62, P <0.001) with important clinical exceptions. There was negative correlation between the PV and Qmax (r s

= 0.62, P <0.001) with important clinical exceptions. There was negative correlation between the PV and Qmax (r s Original Article 60 Relationships between Prostatic Volume and Intravesical Prostatic Protrusion on Transabdominal Ultrasound and Benign Prostatic Obstruction in Patients with Lower Urinary Tract Symptoms

More information

URINARY TRACT NERVOUS SYSTEM DISORDERS: DRUG THERAPY REVIEW

URINARY TRACT NERVOUS SYSTEM DISORDERS: DRUG THERAPY REVIEW Vet Times The website for the veterinary profession https://www.vettimes.co.uk URINARY TRACT NERVOUS SYSTEM DISORDERS: DRUG THERAPY REVIEW Author : Ian Battersby Categories : Vets Date : August 3, 2009

More information

International Clinical Development Department, Yamanouchi Pharmaceutical Co., Ltd., 17 1 Hasune 3-chome, Itabashi-ku, Tokyo , Japan

International Clinical Development Department, Yamanouchi Pharmaceutical Co., Ltd., 17 1 Hasune 3-chome, Itabashi-ku, Tokyo , Japan 192 Journal of Health Science, 47(2) 192 22 (21) Investigation of the Effects of Tamsulosin on Blood Pressure in Normotensive, Controlled Hypertensive, and Uncontrolled Hypertensive Men with Benign Prostatic

More information

The Pharmacological Profile of the a 1A -Adrenoceptor Antagonist Silodosin

The Pharmacological Profile of the a 1A -Adrenoceptor Antagonist Silodosin EUROPEAN UROLOGY SUPPLEMENTS 9 (2010) 486 490 available at www.sciencedirect.com journal homepage: www.europeanurology.com The Pharmacological Profile of the a 1A -Adrenoceptor Antagonist Silodosin Martin

More information

MODULE 3: BENIGN PROSTATIC HYPERTROPHY

MODULE 3: BENIGN PROSTATIC HYPERTROPHY MODULE 3: BENIGN PROSTATIC HYPERTROPHY KEYWORDS: Prostatic hypertrophy, prostatic hyperplasia, PSA, voiding dysfunction, lower urinary tract symptoms (LUTS) At the end of this clerkship, the medical student

More information

EAU GUIDELINES ON NON- NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION

EAU GUIDELINES ON NON- NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION EAU GUIDELINES ON NON- NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION (Limited text update March 2016) S. Gravas (Chair), T. Bach, A. Bachmann, M. Drake, M. Gacci, C. Gratzke, S. Madersbacher,

More information

ISSN: (Print) (Online) Journal homepage:

ISSN: (Print) (Online) Journal homepage: Archives of Andrology Journal of Reproductive Systems ISSN: 0148-5016 (Print) (Online) Journal homepage: http://www.tandfonline.com/loi/iaan19 CHANGE IN INTERNATIONAL PROSTATE SYMPTOM SCORE AFTER TRANSURETHRAL

More information

OVER 70% OF MEN IN THEIR 60s HAVE SYMPTOMS OF BPH 1

OVER 70% OF MEN IN THEIR 60s HAVE SYMPTOMS OF BPH 1 PATIENT INFORMATION BPH affects more than 500 million men worldwide, with many men suffering from symptoms of enlarged prostate. 1 You no longer have to be one of them! OVER 70% OF MEN IN THEIR 60s HAVE

More information

α-blocker Monotherapy and α-blocker Plus 5-Alpha-Reductase Inhibitor Combination Treatment in Benign Prostatic Hyperplasia; 10 Years Long-Term Results

α-blocker Monotherapy and α-blocker Plus 5-Alpha-Reductase Inhibitor Combination Treatment in Benign Prostatic Hyperplasia; 10 Years Long-Term Results www.kjurology.org http://dx.doi.org/10.4111/kju.2012.53.4.248 Voiding Dysfunction α-blocker Monotherapy and α-blocker Plus 5-Alpha-Reductase Inhibitor Combination Treatment in Benign Prostatic Hyperplasia;

More information

A Comparison of the Frequencies of Medical Therapies for Overactive Bladder in Men and Women: Analysis of More Than 7.2 Million Aging Patients

A Comparison of the Frequencies of Medical Therapies for Overactive Bladder in Men and Women: Analysis of More Than 7.2 Million Aging Patients EUROPEAN UROLOGY 57 (2010) 586 591 available at www.sciencedirect.com journal homepage: www.europeanurology.com Platinum Priority Voiding Dysfunction Editorial by Roger Dmochowski on pp. 592 593 of this

More information

NEUROMODULATION FOR UROGYNAECOLOGISTS

NEUROMODULATION FOR UROGYNAECOLOGISTS NEUROMODULATION FOR UROGYNAECOLOGISTS Introduction The pelvic floor is highly complex structure made up of skeletal and striated muscle, support and suspensory ligaments, fascial coverings and an intricate

More information

Lower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics. Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital

Lower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics. Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital Lower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital 01/02/2018 Lower Urinary Tract Symptoms LUTS - one of

More information

Voiding Dysfunction. Jae Hyun Bae, Sun Ouck Kim 1, Eun Sang Yoo 2, Kyung Hyun Moon 3, Yoon Soo Kyung 4, Hyung Jee Kim 4

Voiding Dysfunction. Jae Hyun Bae, Sun Ouck Kim 1, Eun Sang Yoo 2, Kyung Hyun Moon 3, Yoon Soo Kyung 4, Hyung Jee Kim 4 www.kjurology.org DOI:10.4111/kju.2011.52.4.274 Voiding Dysfunction Efficacy and Safety of Low-Dose Propiverine in Patients with Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia with Storage Symptoms:

More information

European Urology 44 (2003) 89 93

European Urology 44 (2003) 89 93 European Urology European Urology 44 (2003) 89 93 Long-Term Evaluation of Transurethral Needle Ablation of the Prostate (TUNA) fortreatment of Symptomatic Benign Prostatic Hyperplasia: Clinical Outcome

More information

Urinary Incontinence in Women: Never an Acceptable Consequence of Aging

Urinary Incontinence in Women: Never an Acceptable Consequence of Aging Urinary Incontinence in Women: Never an Acceptable Consequence of Aging Catherine A. Matthews, MD Associate Professor Chief, Urogynecology and Pelvic Reconstructive Surgery University of North Carolina,

More information

A recent randomized controlled trial of a SMP for patients with LUTS reported positive results. In the group of patients who used the

A recent randomized controlled trial of a SMP for patients with LUTS reported positive results. In the group of patients who used the . JOURNAL COMPILATION 2009 BJU INTERNATIONAL Lower Urinary Tract SELF-MANAGEMENT OF LUTS AND FREQUENCY-VOLUME CHART MEASURES YAP et al. BJUI BJU INTERNATIONAL The impact of self-management of lower urinary

More information

European Urology Supplements 4 (2005) 33 44

European Urology Supplements 4 (2005) 33 44 European Urology Supplements European Urology Supplements 4 (2005) 33 44 Tamsulosin Oral Controlled Absorption System (OCAS) in Patients with Lower UrinaryTract Symptoms Suggestive of Benign Prostatic

More information

PROSTATIC ARTERY EMBOLISATION (PAE) FOR BENIGN PROSTATIC HYPERPLASIA. A Minimally Invasive Innovative Treatment

PROSTATIC ARTERY EMBOLISATION (PAE) FOR BENIGN PROSTATIC HYPERPLASIA. A Minimally Invasive Innovative Treatment PROSTATIC ARTERY EMBOLISATION (PAE) FOR BENIGN PROSTATIC HYPERPLASIA A Minimally Invasive Innovative Treatment What is the prostate? The prostate is an accessory organ of the male reproductive system.

More information

VOIDING DYSFUNCTION IN ELDERLY MALE CURRENT STATUS

VOIDING DYSFUNCTION IN ELDERLY MALE CURRENT STATUS VOIDING DYSFUNCTION IN ELDERLY MALE CURRENT STATUS DR. FRANCIS LEE Voiding dysfunction Storage Emptying Common voiding dysfunction in elderly male Emptying BPH Storage Incontinence Overactive bladder Post-prostatectomy

More information

EAU GUIDELINES ON NON- NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION

EAU GUIDELINES ON NON- NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION EAU GUIDELINES ON NON- NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION (Text update March 2017) S. Gravas (Chair), T. Bach, M. Drake, M. Gacci, C. Gratzke, T.R.W. Herrmann, S. Madersbacher,

More information

Functional Bladder Problems

Functional Bladder Problems european urology supplements 6 (2007) 710 716 available at www.sciencedirect.com journal homepage: www.europeanurology.com Functional Bladder Problems Emmanuel Chartier-Kastler * Department of Urology,

More information